Drug Executive Collapses During Oval Office Press Conference
A drug executive fainted during a press conference in the Oval Office while President Donald Trump announced a deal with pharmaceutical companies to reduce obesity drug prices.
Incident Details
The event was interrupted when Gordon Findlay, Novo Nordisk's global brand director, suddenly collapsed. This happened as President Trump and drugmakers Eli Lilly and Novo Nordisk discussed expanding coverage and lowering prices for obesity treatments Zepbound and Wegovy.
Immediate Response
During remarks from David Ricks, Eli Lilly’s CEO, he noticed the incident and asked,
“Are you okay? Gordon, are you okay?”Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly assisted Findlay as he fell to his knees. The press was then asked to leave the room.
Aftermath
Health and Human Services Secretary was present during the incident. Approximately 30 minutes later, the press conference resumed with President Trump providing an update on Findlay’s health.
Key Figures Present
- President Donald Trump
- Gordon Findlay, Novo Nordisk
- David Ricks, Eli Lilly CEO
- Dr. Mehmet Oz, CMS Administrator
- Health and Human Services Secretary
“Are you okay? Gordon, are you okay?” — David Ricks during the incident
Summary: During a White House press event on obesity drug pricing, Novo Nordisk’s Gordon Findlay collapsed, prompting immediate aid from Dr. Mehmet Oz and a brief pause in the conference.
Would you like the summary sentence to be more formal or conversational?